First test of new hepatitis c drug begins in small patient group
NCT ID NCT00591214
Summary
This was a very early study to check the safety and basic behavior of a new drug called MP-424 in people with a specific type of chronic Hepatitis C. It involved just 10 patients who had never taken certain other Hepatitis C medications. Researchers gave a single dose and then carefully tracked how the drug moved through the body and whether it affected the level of the Hepatitis C virus over several months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS C are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Toranomon Hospital
Kawasaki, Takatsu-ku, Japan
Conditions
Explore the condition pages connected to this study.